CorMedix Inc. (CRMD) Guidance & Earnings Results

On 2026-08-13 CorMedix Inc. raised guidance: "FY2026 adjusted EBITDA guidance raised to $125-$140M from prior; revenue guidance maintained at…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CRMDCorMedix Inc.Follow CRMD — free

Biotechnology · Healthcare

—

Price chart with a free account

Market cap: 611.9M
P/E TTM: 3.8
Dividend yield: —
52-week: —
Next earnings: 11 Nov, in 18 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
13 Aug 26	Raised	FY2026 adjusted EBITDA guidance raised to $125-$140M from prior; revenue guidance maintained at $325-$345M · full year
14 May 26	Raised	FY2026 revenue $325-345M, adjusted EBITDA $115-135M · full year
5 Mar 26	Reaffirmed	FY2026 net revenue $300-$320M, adjusted EBITDA $100-$125M · full year
8 Jan 26	Raised	FY2026 revenue guidance $300-320M · full year
12 Nov 25	Raised	FY2025 pro forma net revenue guidance raised to $390-$410M from prior; adjusted EBITDA guidance raised to $220-$240M · full year
20 Oct 25	Raised	FY 2025 pro forma net revenue guidance raised from $325-$350M to at least $375M · full year

CorMedix Inc. — questions

What guidance did CorMedix Inc. give?: On 2026-08-13: "FY2026 adjusted EBITDA guidance raised to $125-$140M from prior; revenue guidance maintained at $325-$345M"
When does CorMedix Inc. report earnings?: CorMedix Inc.'s next earnings report is expected on 2026-11-11.

Every figure on this page comes from CorMedix Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.